To investigate whether 6-ORLs predictive signature still have predictive ability for OS in TCGA glioma patients in different clinicopathological variable classifications, TCGA glioma patients were classified according to age, gender, WHO grade, IDH mutation, 1p19q codeletion, MGMT promoter methylation into several groups. The gene discussed is MGMT; the disease is central nervous system cancer.